A Hypocaloric Protein-rich Diet Before Metabolic Surgery Improves Liver Function in Patients with Obesity and Diabetes : A Secondary Analysis of a Randomized Clinical Trial

Overview

Journal Langenbecks Arch Surg

Date 2025 Jan 13

PMID 39804512

Authors

Natalie Kronert

Yusef Moulla

Undine Gabriele Lange

Matthias Bluher

Nicolas Linder

Alexander Fuhrmann

Harald Busse

Anna Linder

Thomas Karlas

Johannes Wiegand

Roland Morgenroth

Lena Seidemann

Arne Dietrich

Affiliations

Soon will be listed here.

Abstract

Purpose: Obesity and type 2 diabetes (T2DM) are major risk factors for hepatic steatosis. Diet or bariatric surgery can reduce liver volume, fat content, and inflammation. However, little is known about their effects on liver function, as evaluated here using the LiMAx test.

Methods: In the MetaSurg study (RCT on the effects of different Roux-en-Y gastric bypass (RYGB) limb lengths on diabetes remission in patients with BMI ≥ 27 to ≤ 60 kg/m and T2DM; trial registration: DRKS00007810, German Clinical Trials Register Freiburg), 24 consecutive patients underwent liver function (LiMAx) and imaging assessments (MRI, transient elastography; TE) before and after diet and surgery. Two weeks before surgery, the patients received a hypocaloric protein-rich diet.

Results: Nine of 18 patients had a pathologic LiMAx value (≤ 315 µg/kg/h) at baseline. After two weeks of diet, LiMAx values improved (p = 0.01, paired t test, n = 15). LiMAx values further recovered six months after RYGB (p = 0.01, paired t test, n = 15), which was accompanied by decreased liver volumes (p = 0.005, paired t test, n = 10), proton density fat fraction (p = 0.003, paired t test, n = 12), and TE measurements (p = 0.032, paired t test, n = 14). The need for medical diabetes treatment decreased from 100 to 35%.

Conclusion: Liver function improved after a two-week hypocaloric protein-rich diet and metabolic surgery in patients with obesity and T2DM. These data suggest that a two-week diet for this group of patients prior to abdominal surgery could improve a presumably impaired liver function.

References

Polyzos S, Kountouras J, Mantzoros C . Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2018; 92:82-97. DOI: 10.1016/j.metabol.2018.11.014. View

Ott-Fontes P, Diedrich Neto J, Goldoni M . Comparison of the severity of non-alcoholic fatty liver disease in diabetic and non-diabetic obese patients. Rev Col Bras Cir. 2020; 47:e20202485. DOI: 10.1590/0100-6991e-20202485. View

Ssentongo P, Ssentongo A, Dykes T, Pauli E, Soybel D . Nonalcoholic Fatty Liver Disease as a High-Value Predictor of Postoperative Hyperglycemia and Its Associated Complications in Major Abdominal Surgery. J Am Coll Surg. 2018; 227(4):419-429.e6. DOI: 10.1016/j.jamcollsurg.2018.07.655. View

Karlas T, Dietrich A, Peter V, Wittekind C, Lichtinghagen R, Garnov N . Evaluation of Transient Elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) Score for Detection of Fibrosis in Morbidly Obese Patients. PLoS One. 2015; 10(11):e0141649. PMC: 4631322. DOI: 10.1371/journal.pone.0141649. View

Yokoo T, Serai S, Pirasteh A, Bashir M, Hamilton G, Hernando D . Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. Radiology. 2017; 286(2):486-498. PMC: 5813433. DOI: 10.1148/radiol.2017170550. View

McTigue K, Wellman R, Nauman E, Anau J, Coley R, Odor A . Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study. JAMA Surg. 2020; 155(5):e200087. PMC: 7057171. DOI: 10.1001/jamasurg.2020.0087. View

Han J, Shin H, Ahn Y, Cho H, Cheong J, Park B . Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus. Sci Rep. 2022; 12(1):2538. PMC: 8847663. DOI: 10.1038/s41598-022-06205-8. View

Alizai P, Lurje I, Kroh A, Schmitz S, Luedde T, Andruszkow J . Noninvasive Evaluation of Liver Function in Morbidly Obese Patients. Gastroenterol Res Pract. 2019; 2019:4307462. PMC: 6378040. DOI: 10.1155/2019/4307462. View

Alizai P, Wendl J, Roeth A, Klink C, Luedde T, Steinhoff I . Functional Liver Recovery After Bariatric Surgery--a Prospective Cohort Study with the LiMAx Test. Obes Surg. 2015; 25(11):2047-53. DOI: 10.1007/s11695-015-1664-0. View

10.

Schmitz S, Kroh A, Koch A, Brozat J, Stier C, Neumann U . Comparison of Liver Recovery After Sleeve Gastrectomy and Roux-en-Y-Gastric Bypass. Obes Surg. 2021; 31(7):3218-3226. PMC: 8175244. DOI: 10.1007/s11695-021-05390-1. View

11.

Stockmann M, Lock J, Riecke B, Heyne K, Martus P, Fricke M . Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg. 2009; 250(1):119-25. DOI: 10.1097/SLA.0b013e3181ad85b5. View

12.

Garteiser P, Castera L, Coupaye M, Doblas S, Calabrese D, Dioguardi Burgio M . Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates. JHEP Rep. 2021; 3(6):100381. PMC: 8578045. DOI: 10.1016/j.jhepr.2021.100381. View

13.

Fagenson A, Pitt H, Moten A, Karhadkar S, Di Carlo A, Lau K . Fatty liver: The metabolic syndrome increases major hepatectomy mortality. Surgery. 2020; 169(5):1054-1060. DOI: 10.1016/j.surg.2020.11.021. View

14.

Younossi Z, Golabi P, Paik J, Henry A, Van Dongen C, Henry L . The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023; 77(4):1335-1347. PMC: 10026948. DOI: 10.1097/HEP.0000000000000004. View

15.

Coleman K, Wellman R, Fitzpatrick S, Conroy M, Hlavin C, Lewis K . Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort. JAMA Surg. 2022; 157(10):897-906. PMC: 9434478. DOI: 10.1001/jamasurg.2022.3714. View

16.

Everhart J, Bambha K . Fatty liver: think globally. Hepatology. 2010; 51(5):1491-3. DOI: 10.1002/hep.23659. View

17.

Dietrich C, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L . EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). Ultraschall Med. 2017; 38(4):e16-e47. DOI: 10.1055/s-0043-103952. View

18.

Lange U, Moulla Y, Schutz T, Bluher M, Peter V, Shang E . Effectiveness and Tolerability of a Two-Week Hypocaloric Protein-Rich Diet Prior to Obesity Surgery with Two Different Diet Interventions: a Prospective Randomized Trial. Obes Surg. 2022; 32(9):2903-2913. PMC: 9392692. DOI: 10.1007/s11695-022-06180-z. View

19.

Hafeez S, Ahmed M . Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?. J Obes. 2013; 2013:839275. PMC: 3569911. DOI: 10.1155/2013/839275. View

20.

Alon L, Corica B, Raparelli V, Cangemi R, Basili S, Proietti M . Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Prev Cardiol. 2021; 29(6):938-946. DOI: 10.1093/eurjpc/zwab212. View